Showing results (201-210 of 223) with videos related to
Sort By:
Pageof 23
Alimentary Pharmacology & Therapeutics|April 1, 1990
Omeprazole or high-dose ranitidine in the treatment of patients with reflux oesophagitis not responding to 'standard doses' of H2-receptor antagonistsL Lundell, L Backman, P Ekström, et al.Hepato-Gastroenterology|August 1, 1991
The effect of omeprazole and ranitidine on ulcer healing, relief of symptoms, and incidence of adverse events in the treatment of duodenal ulcer patientsL Kager, G Lindberg, L H Nilsson, et al.Arthritis Care & Research|February 15, 2019
Men and Women's Occupational Activities and the Risk of Developing Osteoarthritis of the Knee, Hip, or Hands: A Systematic Review and Recommendations for Future ResearchMonique A M Gignac, Emma Irvin, Kim Cullen, et al.Clinical Transplants|January 1, 1993
Baylor update: outcome analysis in liver transplantationM F Levy, R M Goldstein, B S Husberg, et al.Scandinavian Journal of Gastroenterology|March 1, 1991
Prevention of relapse of reflux esophagitis after endoscopic healing: the efficacy and safety of omeprazole compared with ranitidineL Lundell, L Backman, P Ekström, et al.Plos One|November 2, 2018
Development and pre-testing of the Patient Engagement In Research Scale (PEIRS) to assess the quality of engagement from a patient perspectiveClayon B Hamilton, Alison M Hoens, Shanon McQuitty, et al.Arthritis Care & Research|March 1, 2021
Perspectives of Persons With Arthritis on the Use of Wearable Technology to Self Monitor Physical Activity: A Qualitative Evidence SynthesisJenny Leese, Jasmina Geldman, Siyi Zhu, et al.Journal of Pediatric Nursing|January 22, 2008
Concurrent validity of the Harris Infant Neuromotor Test and the Alberta Infant Motor ScaleLillian Tse, Tanja A Mayson, Sara Leo, et al.Trials|December 13, 2019
Effectiveness of an online self-management tool, OPERAS (an On-demand Program to EmpoweR Active Self-management), for people with rheumatoid arthritis: a research protocolJohnathan Tam, Diane Lacaille, Teresa Liu-Ambrose, et al.The New England Journal of Medicine|January 15, 1998
Interleukin-2-receptor blockade with daclizumab to prevent acute rejection in renal transplantation. Daclizumab Triple Therapy Study GroupF Vincenti, R Kirkman, S Light, et al.Pageof 23